B. Hofilena

A new family of H3 receptor antagonists based on the natural product Conessine.

V. Santora, J. Knudsen, C. Sage, 2008, Bioorganic & medicinal chemistry letters.

Novel H3 receptor antagonists with improved pharmacokinetic profiles.

V. Santora, John Covel, Albert S. Ren, 2008, Bioorganic & medicinal chemistry letters.

SM04755, a small‐molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy

J. Hood, C. Barroga, Y. Yazici, 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

SAT 0604 AUTOLOGOUS BLOOD AND CORTICOSTEROID LOCAL INJECTION IN TREATMENT OF PLANTAR FASCIITIS ( RANDOMIZED , CONTROLLED MULTICENTER CLINICAL TRIAL )

Y. Yazici, B. Hofilena, M. Ibanez, 2022 .

TAU PATHOLOGY REDUCTION WITH SM07883, A NOVEL, POTENT, AND SELECTIVE ORAL DYRK1A INHIBITOR: A POTENTIAL THERAPEUTIC FOR ALZHEIMER’S DISEASE

B. Melchior, C. Swearingen, Y. Yazici, 2018, Alzheimer's & Dementia.

Experimental tendinopathy treatment with SM04755, a topical small molecule inhibitor of the WNT pathway

Y. Yazici, B. Hofilena, L. Dellamary, 2018 .

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease

B. Melchior, B. Hofilena, D. S. Herman, 2019, Aging cell.